Duncker Streett & CO Inc Gilead Sciences, Inc. Transaction History

Duncker Streett & CO Inc

$542 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$63.15 - $72.88 $25,260 - $29,152	-400 Reduced 72.73%	150 $10,000
Q4 2022 Jan 25, 2023	BUY	$62.32 - $89.47 $24,928 - $35,788	400 Added 266.67%	550 $0
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $17,376 - $21,774	-300 Reduced 66.67%	150 $9,000
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $32,152 - $34,689	-475 Reduced 51.35%	450 $31,000
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $19,041 - $20,805	-300 Reduced 24.49%	925 $64,000
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $69,000 - $78,729	-1,150 Reduced 48.42%	1,225 $79,000
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $36,822 - $41,957	-650 Reduced 21.49%	2,375 $138,000
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $21,702 - $25,200	-300 Reduced 9.02%	3,025 $233,000
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $4,759 - $6,096	76 Added 2.34%	3,325 $249,000
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $81,400 - $89,537	-1,321 Reduced 28.91%	3,249 $211,000
Q3 2019 Oct 31, 2019	BUY	$62.51 - $69.0 $31,380 - $34,638	502 Added 12.34%	4,570 $290,000
Q2 2019 Jul 24, 2019	SELL	$61.87 - $69.38 $36,936 - $41,419	-597 Reduced 12.8%	4,068 $275,000
Q1 2019 Apr 29, 2019	BUY	$62.53 - $70.05 $125 - $140	2 Added 0.04%	4,665 $303,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $36,202 - $47,242	-598 Reduced 11.37%	4,663 $292,000
Q3 2018 Oct 22, 2018	SELL	$71.28 - $78.92 $16,251 - $17,993	-228 Reduced 4.15%	5,261 $406,000
Q2 2018 Jul 23, 2018	BUY	$64.88 - $75.68 $194 - $227	3 Added 0.05%	5,489 $389,000
Q1 2018 Apr 26, 2018	BUY	$72.84 - $88.8 $80,124 - $97,680	1,100 Added 25.08%	5,486 $414,000
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $66,169 - $77,673	-930 Reduced 17.49%	4,386 $314,000
Q3 2017 Oct 25, 2017	BUY	$72.11 - $85.47 $383,336 - $454,358	5,316	5,316 $431,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.

Account